The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 02, 2015

Filed:

Nov. 18, 2011
Applicants:

Stephen L. Bolea, Watertown, MN (US);

Robert S. Kieval, Medina, MN (US);

Bruce J. Persson, Albertville, MN (US);

David J. Serdar, Shorewood, MN (US);

Peter T. Keith, St. Paul, MN (US);

Eric D. Irwin, Minneapolis, MN (US);

Martin A. Rossing, Coon Rapids, MN (US);

Inventors:

Stephen L. Bolea, Watertown, MN (US);

Robert S. Kieval, Medina, MN (US);

Bruce J. Persson, Albertville, MN (US);

David J. Serdar, Shorewood, MN (US);

Peter T. Keith, St. Paul, MN (US);

Eric D. Irwin, Minneapolis, MN (US);

Martin A. Rossing, Coon Rapids, MN (US);

Assignee:

CVRx, Inc., Minneapolis, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 1/00 (2006.01); A61N 1/36 (2006.01); A61B 5/02 (2006.01); A61N 1/05 (2006.01); A61N 1/08 (2006.01); A61N 1/37 (2006.01);
U.S. Cl.
CPC ...
A61N 1/36053 (2013.01); A61B 5/02028 (2013.01); A61N 1/05 (2013.01); A61N 1/0551 (2013.01); A61N 1/056 (2013.01); A61N 1/08 (2013.01); A61N 1/36114 (2013.01); A61N 1/36117 (2013.01); A61N 1/36185 (2013.01); A61N 1/3702 (2013.01); A61N 1/3611 (2013.01); A61N 1/36135 (2013.01);
Abstract

Devices, systems and methods are described by which the blood pressure, nervous system activity, and neurohormonal activity may be selectively and controllably reduced by activating baroreceptors. A baroreceptor activation device is positioned near a baroreceptor, preferably a baroreceptor located in the carotid sinus. A control system may be used to modulate the baroreceptor activation device. The control system may utilize an algorithm defining a stimulus regimen which promotes long term efficacy and reduces power requirements/consumption. The baroreceptor activation device may utilize electrodes to activate the baroreceptors. The electrodes may be adapted for connection to the carotid arteries at or near the carotid sinus, and may be designed to minimize extraneous tissue stimulation.


Find Patent Forward Citations

Loading…